Influence of rapamycin combined with cyclosporin A eye drops on rejection reaction after high-risk corneal transplantation in rats

Bing Li,Jing Hong,Ben Zhang,Y. Ding
2007-01-01
Abstract:Aim: To observe the immunosuppressive effect of rapamycin eye drops on immunological rejection after high-risk corneal transplantation in rats, and observe the effects of eye drops combined with cyclosporin A. Methods: The experiment was performed at the Animal Laboratory of Liaoning Medical University from December 2004 to March 2005. Totally 50 healthy male SD rats were used as recipients, and 23 female Wistar rats were used as donors. SD rats with corneal vascularization were taken as recipients to establish animal model of high-risk penetrative corneal transplantation. 1 Totally 40 recipients were involved in the result analysis, and randomly assigned into 4 groups, 10 rats in each group. Control group (ophthalmic solution solvent), Rapamycin-treated group (2 g/L rapamycin eye drops), Cyclosporin A-treated group (10 g/L cyclosporin A eye drops), 100 μL every time; Rapamycin and cyclosporin A-treated group (2 g/L rapamycin eye drops 50 μL and 10 g/L cyclosporin A eye drops 50 μL). The animals were given the drugs 4 times every day from the 2nd day after operation, and the animals were administered until rejection. 2 The corneal grafts were inspected by slit-lamp microscope clinically. The sum of turbidness, hydroncus and new vessels was as rejection reaction index on that day. When the index ≥ 5 or turbidness of grafts reached 3, it was considered the occurrence of rejection reaction. The corneal survival time was recorded. 3 At day 14 after corneal transplantation, 4 animals in each group were randomly selected for corneal histological test. Results: Totally 40 rats were involved in the result analysis. 1 Comparison of corneal survival time in each group: The corneal survival time in the Control group, Rapamycin-treated group, Cyclosporin A-treated group and Rapamycin and cyclosporin A-treated group was (7.67±1.03, 16.67±1.63, 15.50±2.43, 21.33±2.94) days, respectively. The survival time of the corneal grafts in each treated group was significantly prolonged as compared with the Control group (P < 0.01). The combined medicine group was significantly superior to the simple medicine group (P < 0.01). There was no significant difference between the Rapamycin-treated group and Cyclosporin A-treated group (P > 0.05). 2 Corneal histomorphology change at day 14 after corneal transplantation in each group: The inflammation cells, neovascularity and edema of the corneal grafts in each treated group were significantly fewer than those in the Control group, and there were no inflammation cells and neovascularity in the center of the grafts in combined treated group. Conclusion: 2 g/L rapamycin eye drops can markedly prolong the survival time of corneal grafts in high-risk corneal transplantation. The combined therapy with 10 g/L cyclosporin A eye drops produces synergistic effect, and the therapeutic efficacy is superior to rapamycin or cyclosporin A alone.
What problem does this paper attempt to address?